Trials Of Leadless Pacemakers Comes Under US FDA Panel Spotlight
This article was originally published in Clinica
Executive Summary
The US FDA’s Circulatory System Devices Advisory Panel will discuss the design of clinical trials and post-approval studies for leadless cardiac pacemaker devices at a meeting in Gaithersburg, Maryland on Feb 18.